RJA
Raymond James & Associates’s Pfizer PFE Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | $238M | Sell |
8,209,415
-349,305
| -4% | -$10.1M | 0.14% | 123 |
|
2024
Q2 | $239M | Sell |
8,558,720
-204,765
| -2% | -$5.73M | 0.16% | 106 |
|
2024
Q1 | $243M | Buy |
8,763,485
+925,960
| +12% | +$25.7M | 0.16% | 102 |
|
2023
Q4 | $226M | Sell |
7,837,525
-771,857
| -9% | -$22.2M | 0.17% | 106 |
|
2023
Q3 | $286M | Sell |
8,609,382
-135,019
| -2% | -$4.48M | 0.24% | 73 |
|
2023
Q2 | $321M | Sell |
8,744,401
-109,770
| -1% | -$4.03M | 0.26% | 68 |
|
2023
Q1 | $361M | Buy |
8,854,171
+311,509
| +4% | +$12.7M | 0.31% | 59 |
|
2022
Q4 | $438M | Buy |
8,542,662
+348,547
| +4% | +$17.9M | 0.4% | 44 |
|
2022
Q3 | $359M | Buy |
8,194,115
+164,241
| +2% | +$7.19M | 0.36% | 49 |
|
2022
Q2 | $421M | Buy |
8,029,874
+74,191
| +0.9% | +$3.89M | 0.41% | 42 |
|
2022
Q1 | $412M | Buy |
7,955,683
+543,445
| +7% | +$28.1M | 0.35% | 54 |
|
2021
Q4 | $438M | Sell |
7,412,238
-151,716
| -2% | -$8.96M | 0.35% | 53 |
|
2021
Q3 | $325M | Sell |
7,563,954
-1,147,412
| -13% | -$49.4M | 0.29% | 62 |
|
2021
Q2 | $341M | Buy |
8,711,366
+558,427
| +7% | +$21.9M | 0.31% | 57 |
|
2021
Q1 | $295M | Sell |
8,152,939
-660,488
| -7% | -$23.9M | 0.3% | 59 |
|
2020
Q4 | $324M | Sell |
8,813,427
-854,528
| -9% | -$31.5M | 0.36% | 52 |
|
2020
Q3 | $355M | Sell |
9,667,955
-786,766
| -8% | -$28.9M | 0.44% | 42 |
|
2020
Q2 | $342M | Sell |
10,454,721
-4,278,478
| -29% | -$140M | 0.46% | 38 |
|
2020
Q1 | $481M | Buy |
14,733,199
+327,154
| +2% | +$10.7M | 0.76% | 17 |
|
2019
Q4 | $564M | Buy |
14,406,045
+1,837,440
| +15% | +$72M | 0.72% | 21 |
|
2019
Q3 | $452M | Buy |
12,568,605
+1,980,253
| +19% | +$71.2M | 0.63% | 21 |
|
2019
Q2 | $459M | Buy |
10,588,352
+769,699
| +8% | +$33.3M | 0.66% | 21 |
|
2019
Q1 | $417M | Sell |
9,818,653
-338,238
| -3% | -$14.4M | 0.63% | 21 |
|
2018
Q4 | $443M | Sell |
10,156,891
-734,402
| -7% | -$32.1M | 0.77% | 17 |
|
2018
Q3 | $480M | Buy |
10,891,293
+334,410
| +3% | +$14.7M | 0.74% | 15 |
|
2018
Q2 | $383M | Buy |
10,556,883
+940,153
| +10% | +$34.1M | 0.64% | 20 |
|
2018
Q1 | $341M | Buy |
9,616,730
+401,662
| +4% | +$14.3M | 0.61% | 20 |
|
2017
Q4 | $334M | Buy |
9,215,068
+363,546
| +4% | +$13.2M | 0.61% | 21 |
|
2017
Q3 | $316M | Buy |
8,851,522
+331,993
| +4% | +$11.9M | 0.63% | 20 |
|
2017
Q2 | $286M | Buy |
8,519,529
+503,898
| +6% | +$16.9M | 0.62% | 21 |
|
2017
Q1 | $274M | Buy |
8,015,631
+621,555
| +8% | +$21.3M | 0.64% | 20 |
|
2016
Q4 | $240M | Buy |
7,394,076
+568,547
| +8% | +$18.5M | 0.61% | 22 |
|
2016
Q3 | $231M | Buy |
6,825,529
+1,078,678
| +19% | +$36.5M | 0.63% | 20 |
|
2016
Q2 | $202M | Buy |
5,746,851
+384,873
| +7% | +$13.6M | 0.63% | 20 |
|
2016
Q1 | $159M | Sell |
5,361,978
-166,718
| -3% | -$4.94M | 0.54% | 30 |
|
2015
Q4 | $178M | Buy |
5,528,696
+639,391
| +13% | +$20.6M | 0.64% | 20 |
|
2015
Q3 | $154M | Buy |
4,889,305
+434,890
| +10% | +$13.7M | 0.63% | 21 |
|
2015
Q2 | $149M | Buy |
4,454,415
+654,722
| +17% | +$22M | 0.57% | 20 |
|
2015
Q1 | $132M | Buy |
3,799,693
+416,282
| +12% | +$14.5M | 0.58% | 22 |
|
2014
Q4 | $105M | Buy |
3,383,411
+1,142,586
| +51% | +$35.6M | 0.51% | 28 |
|
2014
Q3 | $66.3M | Buy |
2,240,825
+38,585
| +2% | +$1.14M | 0.38% | 45 |
|
2014
Q2 | $65.4M | Buy |
2,202,240
+108,606
| +5% | +$3.22M | 0.4% | 41 |
|
2014
Q1 | $67.2M | Buy |
2,093,634
+87,127
| +4% | +$2.8M | 0.46% | 34 |
|
2013
Q4 | $61.5M | Sell |
2,006,507
-206,536
| -9% | -$6.33M | 0.46% | 32 |
|
2013
Q3 | $63.6M | Buy |
2,213,043
+115,792
| +6% | +$3.33M | 0.55% | 24 |
|
2013
Q2 | $58.7M | Buy |
+2,097,251
| New | +$58.7M | 0.55% | 26 |
|